Patent Assignment
Reel/Frame 069254/0413
Security Interest
Recorded: 2024-11-13
Pages: 13
Assignee
PIPER SANDLER FINANCE LLC, AS COLLATERAL AGENT
1251 AVENUE OF THE AMERICAS, 6TH FLOOR, NEW YORK, NEW YORK, 10020
Covered Properties
(43)
Sublingual and Buccal Film Compositions
Injectable Flowable Composition Comprising Buprenorphine
Compositions Comprising Buprenorphine
Injectable Flowable Composition Comprising Buprenorphine
Injectable Flowable Composition Buprenorphine
Sublingual and Buccal Film Compositions
Injectable Flowable Composition Comprising Buprenorphine
Compositions Comprising Buprenorphine
Sustained-Release Buprenorphine Solutions
Injectable Composition Comprising Buprenorphine
Therapeutic Compounds as Inhibitors of the Orexin-1 Receptor
Dopamine D3 Receptor Antagonist Compounds
Buprenorphine Dosing Regimens
Injectable Flowable Composition Comprising Buprenorphine
SUBSTITUTED HEXAHYDROPYRROLO[3,4-b]PYRROLES AND HEXAHYDROCYCLOPENTA[c]PYRROLES AS DOPAMINE RECEPTOR MODULATORS
Dopamine D3 Receptor Antagonists Having a Morpholine Moiety
Injectable Flowable Composition Comprising Buprenorphine
Injectable Flowable Composition Comprising Buprenorphine
Dopamine D3 Receptor Antagonists
Sustained-Release Buprenorphine Solutions
Methods to Treat Opioid Use Disorder
Syringe System
Therapeutic Compounds
Dopamine D3 Receptor Antagonist Compounds
Substituted 3,6-Diazabicyclo[3.2.0]Heptanes
Sublingual and Buccal Film Compositions
Compositions and Methods for the Treatment of Opioid Overdose
Injectable Flowable Composition Comprising Buprenorphine
Therapeutic Compounds as Inhibitors of the Orexin-1 Receptor
Therapeutic Compounds
Buprenorphine Dosing Regimens
Buprenorphine to Treat Respiratory Depression
Application:
17/283,931 →
Publication:
US 2021/0393618
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application:
17/291,979 →
Publication:
US 2021/0401827
Therapeutic Compounds
Compositions and Methods for the Treatment of Opioid Overdose
Syringe System
Buprenorphine Dosing Regimens
Application:
17/985,253 →
Publication:
US 2023/0077787
Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
Application:
18/174,858 →
Publication:
US 2023/0225961
Therapeutic Compounds
Formulations and Methods for the Prevention of Opioid Overdose
Application:
18/436,976 →
Publication:
US 2024/0197719
Compositions and Methods for the Treatment of Opioid Overdose
Application:
18/753,188 →
Publication:
US 2025/0127712
Rapid Induction of Monthly Injectable Buprenorphine Extended-Release (Bup-Xr) Compared to Standard of Care Induction
Application:
63/544,747 →
Methods for Administering Buprenorphine
Application:
63/594,785 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 22, 2012
From: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 029167/0310 →
Assignment of Assignor's Interest
Oct 26, 2012
From: MONOSOL RX, LLC
To: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Reel/Frame 029196/0344 →
Security Agreement
Dec 18, 2012
From: MONOSOL RX, LLC
To: WHITE OAK GLOBAL ADVISORS, LLC, AS AGENT
Reel/Frame 029490/0156 →
Assignment of Assignor's Interest
Feb 21, 2013
From: NORTON, RICHARD L.; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 029846/0378 →
Assignment of Assignor's Interest
Feb 21, 2013
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 029846/0335 →
Security Agreement
Apr 30, 2013
From: ALCATEL LUCENT
To: CREDIT SUISSE AG
Reel/Frame 030322/0222 →
Assignment of Assignor's Interest
Apr 21, 2014
From: NORTON, RICHARD L; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 032716/0951 →
Release of Security Interest
Aug 28, 2014
From: CREDIT SUISSE AG
To: ALCATEL LUCENT
Reel/Frame 033654/0968 →
Release of Security Interest
Dec 8, 2014
From: WHITE OAK GLOBAL ADVISORS, LLC
To: MONOSOL RX, LLC
Reel/Frame 034421/0737 →
Grant of Security Interest in Patents
Dec 23, 2014
From: RB PHARMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC. AS COLLATERAL AGENT
Reel/Frame 034696/0885 →
Security Interest
Mar 17, 2015
From: RB PHARMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035186/0121 →
Assignment of Assignor's Interest
May 8, 2015
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 035601/0154 →
Change of Name
Aug 18, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 036388/0861 →
Change of Name
Dec 4, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037218/0769 →
Change of Name
Feb 16, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037837/0908 →
Notice of Grant of Security Interest in Patents
May 10, 2016
From: INDIVIOR UK LIMITED, FORMERLY RB PHAMACEUTICALS LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 038658/0700 →
Release of Security Interest
Aug 22, 2016
From: WHITE OAK GLOBAL ADVISORS, LLC
To: MONOSOL RX, LLC
Reel/Frame 039774/0782 →
Assignment of Assignor's Interest
Sep 9, 2016
From: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 039690/0714 →
Change of Name
Sep 9, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 039981/0280 →
Assignment of Assignor's Interest
Sep 9, 2016
From: MYERS, GARRY L.; HILBERT, SAMUEL D.; BOONE, BILL J.; BOGUE, B. ARLIE
To: MONOSOL RX, LLC
Reel/Frame 039690/0606 →
Assignment of Assignor's Interest
Sep 9, 2016
From: MONOSOL RX, LLC
To: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Reel/Frame 039690/0551 →
Change of Name
Oct 13, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 040351/0089 →
Assignment of Assignor's Interest
Oct 13, 2016
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 040010/0055 →
Change of Name
Nov 7, 2016
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 040575/0332 →
Assignment of Assignor's Interest
Feb 2, 2017
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 041155/0056 →